UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010090 |
|---|---|
| Receipt number | R000011766 |
| Scientific Title | Phase I study of Erlotinib and Crizotinib after ALK inhibitor failure in ALK positive advanced Non-Small Cell Lung Cancer |
| Date of disclosure of the study information | 2013/02/21 |
| Last modified on | 2019/02/26 18:38:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/02/21 13:23:06 | ||
| 2 | Update | 2014/10/04 20:44:06 | TEL TEL Name of person sending information Name of person sending information TEL |
|
| 3 | Update | 2015/02/21 12:23:14 | Email |
|
| 4 | Update | 2018/06/14 12:55:07 | Recruitment status |
|
| 5 | Update | 2018/06/14 12:56:20 | Name of primary person or sponsor Organization Email1 |
|
| 6 | Update | 2019/02/26 18:38:13 | Recruitment status |
